96 results
8-K
ACST
Acasti Pharma Inc - Ordinary Shares
23 Oct 23
Acasti Announces Dosing of First Patient in GTX-104 STRIVE-ON Trial
4:30pm
as to their obligation to deliver the remaining balance of raw krill oil product, and that the Company was therefore required to accept the remaining product commitment … balance of the commitment with AKBM amounted to approximately $2.6 million.
Pursuant to the terms of the Settlement Agreement, in exchange
424B5
vz0ja f9jbil
10 Nov 21
Prospectus supplement for primary offering
7:23am
425
EX-99.1
3u5hm bb7icz
12 Aug 21
Business combination disclosure
11:00am
8-K
EX-99.1
kprgmixjnhk2hlm03
12 Aug 21
Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022
10:57am
8-K
EX-99.1
huxtj7idovk
23 Jul 21
Other Events
8:43am